AI주식인사이트AI Stock Insight
B

메타케어

118000KOSPI

55.8 / 100

Reference Date: 2026-09-08

Financial Score18.5 / 40
News Sentiment16.3 / 25
Momentum11.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 6.0% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

MetaCare operates across four business segments: Pharmaceuticals, Medical, Investment, and Real Estate Development, with the Pharmaceuticals segment contributing 77.2% of total revenue. The company has expanded its market presence through acquisitions, such as J&N Pharm and H Bio&Co, and achieved 2.8% revenue share from Real Estate Development in 2024.

Number of Employees

32people

Average Salary

65.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
440.67Industry Average 15.000.0Point

29.4x industry avg (risky)

PBR
0.24Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-0.18Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
20.74Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼0.7% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲52.5% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -4.3% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 0Negative 1Average Sentiment Score 65

Detailed Momentum

52-week position6.0Point

52w upper range (65%)

Current 1,322Won52-week high 1,90952-week low 208
1-month return2.0Point

1m -5.97% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral반기보고서 (2026.06)2026-08-13